medica glp-1 coverage Weight-Loss Drug Demonstration Begins July 2026 Medicaid Coverage of and Spending
Description
Potential legal claims against Novo Nordisk include: Failure to warn of the side effects Negligent misrepresentation of the drug Fraudulent/intentional concealment of the potential side effects
10.1016/j.jhep.2023.07.033
Liraglutide also helps reduce the risks of cardiovascular problems
Research is limited, but so far, that doesnt seem to be the case
Noria SF, Shelby RD, Atkins KD, et al
This helps prevent spikes in blood sugar levels after meals
